MoonLake Immunotherapeutics - Class A

MLTX NASDAQ Santé & Biotech Suisse KY61559X1045
18.69 $
5.30 %

MoonLake Immunotherapeutics se consacre à développer des thérapies innovantes basées sur les nanocorps pour le traitement des maladies inflammatoires.

Performance & Momentum

6 Months 30.52 %
1 Year 57.72 %
3 Years 27.19 %
5 Years 79.71 %

Similar stocks to MoonLake Immunotherapeutics - Class A

Anantys Community

Be the first to share your analysis on MoonLake Immunotherapeutics - Class A.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases